Trial intelligence / Profile preview

Duloxetine versus sertraline versus placebo in total hip arthroplasty patients with anxiety and depression

ChiCTR1900027005Phase 4Recruiting

Sponsor
West China Hospital of Sichuan University
Start
Oct 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in major depressive disorder (MDD) and anxiety disorder comparing Duloxetine arm, Sertraline arm and Placebo arm (3 arms). Primary endpoint: Depression index. Started Oct 2019; status: recruiting.

02

Drugs

duloxetinesertraline
03

Conditions

major depressive disorder (MDD)anxiety disorder

Beyond the preview

Go deeper on ChiCTR1900027005.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1900027005.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call